Gouvernance KDventures AB OTC Markets

KDEVF

SE0002190926

Gestion des placements et exploitants de fonds

Marché Fermé - OTC Markets			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		-.--%	-

07/09	KD Ventures : un bloc représentant 0,6 % du capital a été négocié	FW
07/09	Umecrine Cognition, société en portefeuille de KD Ventures, obtient deux homologations de brevets aux États-Unis	FW

Comité Exécutif: KDventures AB

Dirigeant

Fonctions occupéesDepuis

Viktor Drvota

61 ans

Chief Executive Officer

01/06/2017

Eva Montgomerie

68 ans

Comptroller/Controller/Auditor

01/01/2007

Johan Dighed

53 ans

General Counsel

01/05/2020

John Öhd

55 ans

Chief Tech/Sci/R&D Officer

01/06/2020

Hans Christopher Toll

58 ans

Director of Finance/CFO

01/10/2022

Mikaela Sörman

Chief Investment Officer

Composition du Conseil d'Administration: KDventures AB

Administrateur

ComitésDepuis

Benjamin Toogood

50 ans

Chairman	18/12/2024
Independent Dir/Board Member	19/02/2021

Anna Lefevre Skjöldebrand

57 ans

Audit Committee	19/02/2021
Compensation Committee	19/02/2021

Theresa Y. Y. Tse

33 ans

Executive Committee Chair	30/06/2015
Nominating Committee Chair	30/06/2015

Karl Härfstrand

69 ans

Director/Board Member

01/05/2025

Will Zeng

33 ans

Director/Board Member

01/01/2024

Philip Duong

36 ans

Director/Board Member	12/01/2022
Independent Dir/Board Member	12/01/2022

Anciens Dirigeants et Administrateurs: KDventures AB

Insider

Fonctions occupées

DepuisJusqu'au

Björn Cochlovius

Director/Board Member	01/06/2020	19/02/2021
Chairman	19/02/2021	01/05/2024

Ping Tse

Director/Board Member

01/01/2015

12/01/2022

Richard Bethell

Chief Executive Officer

11/01/2022

Per Gunnar Ernst Aniansson

Chief Investment Officer	01/03/2021	-
Director of Finance/CFO	01/03/2021	01/10/2022
Investor Relations Contact	-	-

Fredrik Järrsten

Director of Finance/CFO	29/08/2017	01/03/2021
Investor Relations Contact	29/08/2017	01/03/2021

Gunnar Magnus Modee Persson

Director/Board Member	24/05/2017	25/08/2020
Independent Dir/Board Member	24/05/2017	25/08/2020

Hans Lennart Rudolf Wigzell

Director/Board Member	01/01/2006	01/01/2017
Chairman	01/01/2017	20/08/2020
Independent Dir/Board Member	01/10/2013	20/08/2020

Ulf Göran Richenberg

General Counsel	01/01/2008	01/05/2020
Corporate Secretary	-	01/05/2020

Ewa Björling

Director/Board Member

01/11/2017

Christian Henrik Tange

Director of Finance/CFO

01/01/2014

29/08/2017

Jim van Heusden

Chief Executive Officer	03/03/2015	01/06/2017
Investor Relations Contact	03/03/2015	01/06/2017
Public Communications Contact	03/03/2015	01/06/2017

Henrijette Richter

Director/Board Member	14/05/2014	24/05/2017
Independent Dir/Board Member	14/05/2014	24/05/2017

Carl Johan Bertil Sundberg

Director/Board Member	14/05/2014	24/05/2017
Independent Dir/Board Member	14/05/2014	24/05/2017

Bo Jesper Hansen

Chairman	14/05/2013	24/05/2017
Independent Dir/Board Member	14/05/2013	24/05/2017

Hans-Olov Olsson

Director/Board Member

24/05/2017

Khalid Islam

Director/Board Member

01/01/2015

01/01/2017

Terje Kalland

Chief Tech/Sci/R&D Officer	21/04/2011	31/12/2015
Corporate Officer/Principal	-	-

Daniel Bolanowski

Corporate Officer/Principal

21/04/2011

01/12/2015

Bruno Lucidi

Chief Executive Officer

15/10/2014

01/01/2015

Niclas Adler

Director/Board Member	01/01/2015	24/05/2017
Chairman	24/05/2017	-
Independent Dir/Board Member	01/01/2015	24/05/2017

Tomas Odergren

Chief Tech/Sci/R&D Officer

01/10/2012

01/11/2014

Klaus K. Wilgenbus

Director/Board Member	23/05/2012	15/10/2014
Chief Executive Officer	30/09/2014	15/10/2014

Torbjørn Bjerke

Chief Executive Officer

21/04/2011

30/09/2014

Stig Michael Sundström

Corporate Officer/Principal

12/10/2011

01/06/2014

Per-Olof Edin

Director/Board Member	20/04/2011	15/05/2014
Independent Dir/Board Member	12/07/2011	15/05/2014

Rune Fransson

Director/Board Member	20/04/2011	15/05/2014
Independent Dir/Board Member	12/07/2011	15/05/2014

Robert Leslie Holland

Director/Board Member

14/05/2014

Hans Uno Postlind

Corporate Officer/Principal

01/10/2012

Gunilla Anders Ekström

Chief Operating Officer

01/06/2012

Peter Sjöstrand

Director/Board Member	20/04/2011	23/05/2012
Independent Dir/Board Member	12/07/2011	23/05/2012

Vladimir Valeryevich Artamonov

Director/Board Member	23/05/2012	-
Independent Dir/Board Member	23/05/2012	-

Michael Wilhelm Rosenlew

Director/Board Member	20/04/2011	23/05/2012
Independent Dir/Board Member	12/07/2011	23/05/2012

Charlotte Elisabet Edenius

Director/Board Member	23/05/2012	-
Independent Dir/Board Member	23/05/2012	-

Ulrica Slåne Bjerke

Director/Board Member	20/04/2011	23/05/2012
Independent Dir/Board Member	12/07/2011	23/05/2012

Hans-Peter Torsten Ekre

Chief Investment Officer

01/01/2003

01/01/2012

Michael Owens

Comptroller/Controller/Auditor

21/04/2011

01/01/2012

Ray Hill

Director/Board Member	12/07/2011	-
Independent Dir/Board Member	12/07/2011	-

Marek Poszepczynski

Corporate Officer/Principal

01/01/2008

01/01/2010

Fabian Benjamin Christoffer Nordin

Investor Relations Contact	21/04/2011	-
Public Communications Contact	24/08/2011	-

Carl Harald Janson

Corporate Officer/Principal

21/04/2011

Stig Lennart Hansson

Corporate Officer/Principal

01/01/2006

01/01/2008

Sten Gunnar Otto Skolling

Corporate Officer/Principal

21/04/2011

Gunnar Casserstedt

Director of Finance/CFO	21/04/2011	05/07/2012
Corporate Officer/Principal	05/07/2012	-

Ola Flink

Corporate Officer/Principal

21/04/2011

Torsten Rüdiger Goesch

Director/Board Member

Karen Frost

Public Communications Contact

21/04/2011

Erik Nordin

General Counsel

21/04/2011

Elin Waara

General Counsel

21/04/2011

Jonas Fredrik Röök

Corporate Officer/Principal

21/04/2011

Maritha Lundin

Public Communications Contact	09/07/2012	-
Corporate Officer/Principal	21/04/2011	09/07/2012

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	10
Femme	5

Dont comité exécutif

Homme	4
Femme	2

Dont Administrateurs

Homme	4
Femme	2

Karolinska Development AB est une société d'investissement basée en Suède. La société fournit des capitaux aux entreprises de biotechnologie et développe et commercialise des produits biotechnologiques. Ses activités s'exercent dans divers domaines : oncologie, infections et cicatrisation des plaies, santé des femmes, maladies cardiovasculaires et hématologie, équipement médical, diagnostic, formulation pharmaceutique et implants, entre autres. Le portefeuille de produits pharmaceutiques de la société comprend AXL1717 pour le carcinome pulmonaire non à petites cellules (NSCLC), APR-246 pour le cancer de l'ovaire, Sevuparin pour le paludisme, SHACT pour le soulagement de la douleur lors de l'hystéroscopie et de l'insertion d'un dispositif intra-utérin (DIU), et PC-mAB pour le syndrome coronarien aigu (SCA), entre autres. En outre, la société contrôle un certain nombre de filiales, telles qu'Avaris AB, HBV Thernostica AB, KD Incentive AB, KDev Oncology AB et Limone AB.

Employés

Secteur

Gestion des placements et exploitants de fonds

Agenda

12/11 Publication des résultats - Q3 2026

Plus d'informations sur la société